FTV

Analyst Note: Fortive Corporation (FTV)

Date: 2026-06-13 Price: $61.03

1. Structural Readiness

• State: Context-Only (No active technical coil structure defined in the provided data).
• Conservative Entry: — (Not applicable; no breakout level defined).
• Current Price: $61.03.
• Extension: — (No reference entry price to calculate extension).
• ATR at Breakout: — (No breakout event recorded).
• ATR Current: 2.5% (Sub-threshold volatility).
• Pivot Strength: — (No pivot data provided).
• Cap Bucket: Large.
• Sector: Industrials.
• Industry: Industrial Technology / Diversified Industrials.

2. Thesis Layer

• Primary Secular Thesis: AI Infrastructure (Datacenter Capex / Servers / REITs).
• Exposure & Directness: Fortive is a tertiary beneficiary of the AI Infrastructure thesis with low confidence in direct revenue attribution.
• Mechanism: The company does not manufacture servers or datacenter real estate. Its exposure is indirect through its Intelligent Operating Solutions (IOS) segment, specifically via Fluke and ServiceChannel.
• Evidence: Management explicitly states that Fluke "participates in the tool belt for data centers" with products for power quality monitoring, high-voltage diagnostics, and thermal health (E5). Management further notes excitement about the "ongoing operations and maintenance" of data centers, viewing this as a "larger and more durable opportunity" than just the construction phase (E7).
• Weighting: While the AI narrative is a tailwind, the directness is low. The primary revenue driver remains the broad industrial base (manufacturing, healthcare, utilities) rather than pure-play AI hardware. The thesis serves as a sentiment overlay rather than a primary growth engine.

3. The Business

Fortive Corporation is a global industrial technology company specializing in engineered products, software platforms, and services. As of June 2026, the company operates through three primary segments following the separation of its Precision Technologies business into Ralliant Corporation on June 28, 2025 (E19).

• Intelligent Operating Solutions (IOS): This segment provides advanced instrumentation, software, and services for mission-critical workflows. Key brands include Fluke, ServiceChannel, Gordian, Accruent, Industrial Scientific, and Intex.
• *Performance:* Q1 2026 sales growth was driven by favorable pricing (+2.1%) and volume growth (+3.1%), fueled by demand for facilities/asset lifecycle software and gas detection products (E12).
• *AI Integration:* The segment recently introduced Provation Mirror Documentation Assist, an AI-powered voice-driven documentation tool embedded in GI procedure workflows (E6).
• Advanced Healthcare Solutions (AHS): Supplies workflow solutions for healthcare providers, including instrument sterilization, tracking, and biomedical testing.
• *Performance:* Q1 2026 sales growth was driven by favorable pricing (+2.3%) and volume growth (+3.5%), driven by sterilization products and dosimetry services (E13).
• *Brands:* Includes ASP, Censis, Fluke Biomedical, Landauer, and Provation (E17).
• Business Model: The company operates on a hybrid model of hardware sales and recurring revenue.
• *Recurring Revenue:* The majority of remaining performance obligations ($839.9M) are related to subscription-based software and service contracts. Management expects to fulfill ~75% of these obligations within two years and ~90% within three years (E9).
• *Cash Flow:* Trailing twelve-month free cash flow conversion remains north of 100% (E8).

4. Archetype and Conviction

• Archetype: Quality Compounder.
• Fit: The company demonstrates the hallmarks of a quality compounder: consistent core growth (2-3% expected), strong order patterns, high free cash flow conversion (>100%), and a strategic shift toward recurring software revenue.
• Management Expectations: Management reaffirmed full-year adjusted EPS guidance of $2.90 to $3.00 (E1). They expect core growth to trend toward the upper end of the 2-3% range due to strong order patterns (E2).
• Valuation Context: The financial spine indicates a forward consensus EPS of $2.99 for FY1 and $3.22 for FY2 (E35). At a current price of $61.03, the stock trades at approximately 20x FY1 consensus, implying a moderate multiple for a compounder with double-digit FCF conversion.
• Conviction Stack:
• *Thesis Strength:* Moderate. The AI exposure is real but tertiary; the core thesis is industrial efficiency and healthcare workflow optimization.
• *Evidence Quality:* High. Multiple primary sources (earnings transcripts, SEC filings) confirm guidance, order trends, and segment performance.
• *Structural Quality:* Strong. The separation of Precision Technologies (Ralliant) has streamlined the portfolio, and the high FCF conversion supports capital allocation flexibility.
• *Setup Readiness:* Low/Unknown. The lack of technical coil data prevents a structural assessment. The current ATR of 2.5% is sub-threshold, suggesting low volatility and potentially a lack of immediate momentum, though this also reduces downside risk in the short term.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen the Case:
• Confirmation of order growth accelerating beyond the 5% core revenue growth rate (E3).
• Successful monetization of the new AI tools (Provation Mirror) leading to measurable upsell in the AHS segment.
• A technical breakout above a defined resistance level (currently undefined) with volume expansion.
• What Would Invalidate the Case:
• A miss on the reaffirmed EPS guidance of $2.90–$3.00.
• A significant slowdown in order intake, contradicting the "strong order patterns" cited in Q1.
• Gaps in Evidence:
• Specific AI Revenue: While AI tools are mentioned, there is no quantified revenue contribution from AI-specific products in the provided evidence.
• Post-Separation Dynamics: The immediate financial impact of the Ralliant separation on the remaining FTV balance sheet (beyond the guidance) is not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Reaffirmed full-year EPS guidance of $2.90-$3.00; Free cash flow conversion north of 100%; Strong order patterns driving core growth toward upper end of 2-3% range. Key risks: Lack of technical setup data prevents entry/exit timing; AI exposure is tertiary and low confidence; Sub-threshold ATR (2.5%) indicates low volatility/momentum. Sizing hint: Neutral sizing; position size should be determined by the eventual technical setup rather than fundamental conviction alone. Expected path: Management expects core growth to trend toward the upper end of the 2-3% range; software subscription revenue (75% within 2 years) should provide earnings visibility. Expected horizon: 12-18 months for the current guidance cycle to play out and for the software revenue mix to mature. Failure mode to watch: A close below the current price level combined with a miss on the $2.90 EPS floor, which would signal a breakdown in the order-to-revenue conversion.